Journals / Turkish Journal of Pharmaceutical Sciences / 2017 / Cilt: 14 - Sayı: 3

The Ameliorative Effects of Pycnogenol® on Liver Ischemia-Reperfusion Injury in Rats

Sıçanlarda Karaciğer İskemi Reperfüzyon Hasarında Piknogenol®'ün İyileştirici Etkileri

Pages
257–263
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The present results suggest that PYC® treatment might have a role in the prevention of IR-induced oxidative damage by decreasing DNA damage and increasing antioxidant status.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pycnogenol® (PYC®), a standardized extract from the bark of Pinus maritima, consists of different phenolic compounds.
📊
Key Findings & Data:Ischemia was induced and sustained for 45 min, then the ischemic liver was reperfused, which was sustained for a further 120 min at the end of this period.
💡
Conclusion & Impact:Conclusion: The present results suggest that PYC® treatment might have a role in the prevention of IR-induced oxidative damage by decreasing DNA damage and increasing antioxidant status.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Pycnogenol® (PYC®), a standardized extract from the bark of Pinus maritima, consists of different phenolic compounds. PYC® has shown to have protective effects on chronic diseases such as diabetes, asthma, cancer, and immune disorders. The aim of this study was to determine the effects of PYC® against the DNA damage and biochemical changes in blood, liver, and lung tissues of ischemia-reperfusion (IR)-induced Wistar albino rats. Materials and Methods: A sham group, IR injury-induced group, and IR+PYC® group were formed. Ischemia was induced and sustained for 45 min, then the ischemic liver was reperfused, which was sustained for a further 120 min at the end of this period. After anesthesia and before the IR inducement, 100 mg/kg PYC® was given to the IR+PYC® group through intraperitoneal injections. The total oxidant (TOS) and total antioxidant status (TAS), total thiol levels (TTL), advanced oxidation protein products (AOPP), and biochemical parameters [myeloperoxidase (MPO), aspartate aminotransferase (AST), alanine aminotransferase (ALT) and lactate dehydrogenase (LDH)] in the rats were analyzed using spectrophotometric methods and DNA damage was assessed using single-cell gel electrophoresis. Results: The levels of TOS, TTL, MPO, AOPP, ALT, AST, and LDH were significantly decreased in the IR+PYC® group compared with the IR group (p<0.05). The levels of TAS were significantly increased in the IR+PYC® group compared with the IR group (p<0.05). PYC® reduced the DNA damage when compared with the IR group (p<0.05). Conclusion: The present results suggest that PYC® treatment might have a role in the prevention of IR-induced oxidative damage by decreasing DNA damage and increasing antioxidant status.

Özet

Amaç: Piknogenol® (PYC®), Pinus maritima bitkisinin kabuğundan elde edilen ve birkaç tip fenolik içerikten oluşan, suda çözünür standardize bir Bulgular: TOS, TTL, MPO, AOPP, ALT, AST and LDH düzeyleri IR+PYC® grubunda IR grubuna göre anlamlı ölçüde düşük bulundu (p<0.05). TAS düzeyi IR+PYC® grubunda IR grubuna göre anlamlı ölçüde yüksek bulundu (p<0.05). DNA hasarı değerlendirildiğinde PYC® verilen grupta DNA iskemi grubuna göre anlamlı ölçüde azaldığı saptandı (p<0.05).Sonuç: Mevcut bulgular, piknogenol tedavisinin IR ile indüklenmiş oksidatif hasarı DNA hasarını azaltarak ve antioksidan durumu arttırarak da önlediğini göstermektedir.

🔖

Cite This Article

TOKAÇ, M., BACANLI, M., DUMLU, E. G., DİLSİZ, S. A., ENGİN, M., BOZKURT, B., YALÇIN, A., EREL, Ö., KILIÇ, M., BAŞARAN, A. N. (2017). The Ameliorative Effects of Pycnogenol® on Liver Ischemia-Reperfusion Injury in Rats. Turkish Journal of Pharmaceutical Sciences, Cilt: 14 - Sayı: 3, 257–263. https://ajindex.com/articles/403687

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Huguet C, Addario-Chieco P, Gavelli A, Arrigo E, Harb J, Clement RR. Technique of hepatic vascular exclusion for extensive liver resection. Am J Surg. 1992;163:602-605
  2. Delva E, Camus Y, Nordlinger B, Hannoun L, Parc R, Deriaz H, Lienhart A, Huguet C. Vascular occlusions for liver resections. Operative management and tolerance to hepatic ischemia: 142 cases. Ann Surg. 1989;209:211-218
  3. Lee SH, Culberson C, Korneszczuk K, Clemens MG. Differential mechanisms of hepatic vascular dysregulation with mild vs. moderate ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol. 2008;294:G1219-G1226
  4. Jaeschke H, Bautista AP, Spolarics Z, Spitzer JJ. Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats. J Leukoc Biol. 1992;52:377-382
  5. Tejima K, Arai M, Ikeda H, Tomiya T, Yanase M, Inoue Y, Nagashima K, Nishikawa T, Watanabe N, Omata M, Fujiwara K. Ischemic preconditioning protects hepatocytes via reactive oxygen species derived from Kupffer cells in rats. Gastroenterology. 2004;127:1488- 1496
  6. Sahin T, Begeç Z, Toprak Hİ, Polat A, Vardi N, Yücel A, Durmuş M, Ersoy MÖ. The effects of dexmedetomidine on liver ischemia-reperfusion injury in rats. J Surg Res. 2013;183:385-390
  7. Bahde R, Spiegel HU. Hepatic ischaemia-reperfusion injury from bench to bedside. Br J Surg. 2010;97:1461-1475
  8. Çekın AH, Gür G, Türkoğlu S, Aldemır D, Yilmaz U, Gürsoy M, Taşkoparan M, Boyacioğlu S. The protective effect of L-carnitine on hepatic ischemia-reperfusion injury in rats. Turk J Gastroenterol. 2013;24:51-56
  9. Ishikawa F, Miyazaki S. New biodefense strategies by neutrophils. Arch Immunol Ther Exp (Warsz). 2005;53:226-233
  10. Jaeschke H. Reactive oxygen and ischemia/reperfusion injury of the liver. Chem Biol Interact. 1991;79:115-136
  11. Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury: Present concepts. J Gastroenterol Hepatol. 2011;26(Suppl 1):173- 179
  12. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology. 2003;125:917-936
  13. Jegatheeswaran S, Jamdar S, Satyadas T, Sheen AJ, Adam R, Siriwardena AK. Use of Pharmacologic Agents for Modulation of Ischaemia-Reperfusion Injury after Hepatectomy: A Questionnaire Study of the LiverMetSurvey International Registry of Hepatic Surgery Units. HPB Surg. 2014;2014:437159
  14. Maurya DK, Devasagayam TP. Antioxidant and prooxidant nature of hydroxycinnamic acid deriva